Wiregraph

Market coverage built from listed-company disclosures. Email [email protected] for any enquiries.

Copyright © 2025-2026 Wiregraph.com | Market data and charting by TradingView.com

GETINGE B

GETIb.STSE0000202624NASDAQ StockholmSESEK
Stock price
GETINGE B
Loading chart...

Coverage

Latest articles

Getinge defies tariffs with strong growth and improved margins
21 Oct 2025, 06:02GETIb.STNASDAQ Stockholm

Filings

Recent filings

FilingDate
Getinge publish Interim Report January - September 201718 Oct 2017
Getinge announces date of 2017 Q3 report and conference call4 Oct 2017
Change in number of shares and votes in Getinge29 Sept 2017
Getinge appoints Interim CFO26 Sept 2017
Final outcome of Getinge’s rights issue21 Sept 2017
Getinge’s rights issue fully subscribed18 Sept 2017
Getinge publishes prospectus regarding the rights issue25 Aug 2017
Getinge resolves on fully guaranteed rights issue of MSEK 4,324
Search

Swedish medical technology company Getinge AB on Tuesday reported strong third-quarter sales growth and improved profitability, navigating significant headwinds from tariffs and currency fluctuations.

Getinge boosts margins while absorbing significant new tariff costs
18 Jul 2025, 06:01GETIb.STNASDAQ Stockholm

Swedish medical technology company Getinge AB on Friday reported higher second-quarter sales and improved margins, even as it absorbed significant new tariff costs.

18 Aug 2017
Resolutions at Getinge’s Extraordinary General Meeting15 Aug 2017
Getinge to cooperate with Brazilian authorities on local ongoing investigations3 Aug 2017
Notice of Extraordinary General Meeting in Getinge AB17 Jul 2017
Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M17 Jul 2017
  • Previous
  • 1
  • More pages
  • 11
  • 12
  • 13
  • More pages
  • 29
  • Next
Company
GETINGE B
GETIb.STNASDAQ Stockholm
Website: Unavailable
Coverage
2
Filings
345